Increasing the resources for the FDA to oversee drug manufacturing and development abroad would:
Be highly beneficial to ensure the safety and quality of drugs sold in the U.S.
Have a minimal impact in comparison to the market as a whole and potentially cause further problems with thing such as drug cost and availability.
Leave a Comment
Please enter your name.
Please enter your email address.
Your Website (optional)
Please enter a comment.
Created at Crowdsignal.com